Dong Chunsheng相关文献与解析，生知库 | 链接生命科学的每一步

Wu Mengyun, Cai Jiamin, Qiao Guodong, Li Xiaoping, Zhou Ji, Xu Fei, Ye Yunfei, Wang Yufeng, Xu Xuena, Li Jiaoyang, Tian Xiaoyu, Shao Yu, Dong Chunsheng, Chen Zhengrong, Hao Chuangli, Yang Yi, Zhang Jinping

其它

Viral

发表日期：2025

文献求助收藏

Vesicular stomatitis virus-based vaccine targeting plasmodium blood-stage antigens elicits immune response and protects against malaria with protein booster strategy

基于水疱性口炎病毒的疫苗，靶向疟原虫血液期抗原，可诱导免疫反应，并可通过蛋白质加强策略预防疟疾。

期刊:Frontiers in Microbiology

影响因子:4.5

doi:10.3389/fmicb.2022.1042414

Sun, Yifan; Shi, Xiaodan; Lu, Feng; Fu, Haitian; Yin, Yi; Xu, Jiahui; Jin, Cheng; Han, Eun-Taek; Huang, Xuan; Chen, Yongquan; Dong, Chunsheng; Cheng, Yang

A single dose of recombinant VSV-RABV(G) vaccine provides full protection against RABV challenge

单剂重组VSV-RABV(G)疫苗可提供针对狂犬病毒攻击的完全保护。

期刊:Virologica Sinica

影响因子:4

doi:10.1016/j.virs.2022.02.008

Liang, Minglong; Wang, Zongmei; Wu, Chuanjian; Xiong, Sidong; Zhao, Ling; Dong, Chunsheng

Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma

鉴定用于预测鳞状细胞肺癌预后生物标志物的miRNA特征

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0264645

Liu, Huanqing; Li, Tingting; Dong, Chunsheng; Lyu, Jun

Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma

miRNA生物标志物在预测肺腺癌总体生存结局中的应用

期刊:Biomed Research International

影响因子:2.3

doi:10.1155/2022/5249576

Li, Tingting; Liu, Huanqing; Dong, Chunsheng; Lyu, Jun

A novel oncolytic virus engineered with PD-L1 scFv effectively inhibits tumor growth in a mouse model

一种经PD-L1 scFv改造的新型溶瘤病毒可有效抑制小鼠模型中的肿瘤生长

期刊:Cellular & Molecular Immunology

影响因子:19.8

doi:10.1038/s41423-019-0264-7

Wu, Chuanjian; Wu, Manman; Liang, Minglong; Xiong, Sidong; Dong, Chunsheng

Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection

在已接种卡介苗的小鼠中，用重组VSV-846进行异源加强免疫可提高对分枝杆菌感染的保护作用

期刊:Human Vaccines & Immunotherapeutics

影响因子:3.5

doi:10.1080/21645515.2016.1261229

Zhang, Ming; Dong, Chunsheng; Xiong, Sidong

A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection

一种新型疫苗p846编码Rv3615c、Mtb10.4和Rv2660c，可诱导强烈的免疫反应并减轻分枝杆菌感染引起的肺损伤。

期刊:Human Vaccines & Immunotherapeutics

影响因子:3.5

doi:10.4161/hv.27121

Kong, Hongmei; Dong, Chunsheng; Xiong, Sidong

TGF-β in tumor development and progression: mechanisms and therapeutics

TGF-β在肿瘤发生发展中的作用：机制和治疗

Novel signals for naive lymphocyte recruitment under inflammation

炎症条件下幼稚淋巴细胞募集的新信号

RNF149 modulates the type I IFN innate antiviral immune responses through degrading IRF3.

RNF149 通过降解 IRF3 来调节 I 型 IFN 先天性抗病毒免疫反应

Vesicular stomatitis virus-based vaccine targeting plasmodium blood-stage antigens elicits immune response and protects against malaria with protein booster strategy

基于水疱性口炎病毒的疫苗，靶向疟原虫血液期抗原，可诱导免疫反应，并可通过蛋白质加强策略预防疟疾。

A single dose of recombinant VSV-RABV(G) vaccine provides full protection against RABV challenge

单剂重组VSV-RABV(G)疫苗可提供针对狂犬病毒攻击的完全保护。

Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma

鉴定用于预测鳞状细胞肺癌预后生物标志物的miRNA特征

Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma

miRNA生物标志物在预测肺腺癌总体生存结局中的应用

A novel oncolytic virus engineered with PD-L1 scFv effectively inhibits tumor growth in a mouse model

一种经PD-L1 scFv改造的新型溶瘤病毒可有效抑制小鼠模型中的肿瘤生长

Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection

在已接种卡介苗的小鼠中，用重组VSV-846进行异源加强免疫可提高对分枝杆菌感染的保护作用

A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection

一种新型疫苗p846编码Rv3615c、Mtb10.4和Rv2660c，可诱导强烈的免疫反应并减轻分枝杆菌感染引起的肺损伤。